Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.
| Stock | Insider | Value | Type | |||
|---|---|---|---|---|---|---|
| BSXBoston Scientific Corp | Michael F. MahoneyChairman, President & CEO | $9.00M | Added | |||
| Weighted avg $48.33 (range $47.87–$48.47); trade date Aug 3; post-transaction 1,590,024 direct shares; now $47.74 (−1.2% since buy) | ||||||
| APMDApnimed, Inc. | Morningside Venture Investments Ltd10% Owner | $5.00M | Added | |||
| Trade date Aug 3 at $16.00/share; now $26.51 (+65.7% since buy); VC/strategic investor; largest post-buy price gain in this scan | ||||||
| COE51Talk Online Education Group | Huang Jack JiajiaCEO, Director, 10% Owner | $3.35M | Added | |||
| Trade date Jul 30 at $17.21/share; one of 3 separate purchases by CEO (total $8.1M); now $18.99 (+10.3% since buy); late SEC filer | ||||||
| COE51Talk Online Education Group | Huang Jack JiajiaCEO, Director, 10% Owner | $2.87M | Added | |||
| Trade date Jul 28 at $16.88/share; one of 3 separate purchases by CEO; now $18.99 (+12.5% since buy) | ||||||
| CSGPCoStar Group, Inc. | Florance Andrew CFounder & CEO, Director | $2.49M | Added | |||
| Trade date Aug 4 at $29.89/share; now $30.21 (+1.1% since buy); founder/CEO conviction buy | ||||||
| COE51Talk Online Education Group | Huang Jack JiajiaCEO, Director, 10% Owner | $1.84M | Added | |||
| Trade date Jul 29 at $16.91/share; one of 3 separate purchases by CEO; now $18.99 (+12.3% since buy) | ||||||
| TMToyota Motor Corp | Kenta KonPresident | $1.56M | Added | |||
| Trade date Aug 5; purchase in Japanese market in JPY, converted at $18.41/share; post-transaction 148,100 direct shares; TM ADR now $185.89 | ||||||
| GSHDGoosehead Insurance, Inc. | Durable Capital Partners LP10% Owner | $1.41M | Added | |||
| Trade date Jul 31 at $61.88/share; same institution bought second tranche at $62.00 same day ($837K); now $66.95 (+8.2% since buy) | ||||||
| CVNACarvana Co. | Maroone Michael EDirector | $1.30M | Added | |||
| Trade date Jul 31 at $61.69/share; now $69.48 (+12.6% since buy); director already well in the green | ||||||
| IRIngersoll Rand Inc. | Satpathy AurobindExecutive | $1.00M | Added | |||
| Trade date Aug 3 at $86.68/share; now $90.00 (+3.8% since buy) | ||||||
| PFEPfizer Inc | Blaylock Ronald EDirector | $999K | Added | |||
| Trade date Aug 5 at $25.46; post-transaction 66,938 shares direct + 4,750 via trust; now $25.81 (+1.4% since buy); cluster buy same day as Buckley | ||||||
| PFEPfizer Inc | Buckley Mortimer JDirector | $960K | New stake | |||
| Trade date Aug 5 at $25.52; new director first position (former Vanguard CEO); now $25.81 (+1.1% since buy); cluster buy same day as Blaylock | ||||||
| GSHDGoosehead Insurance, Inc. | Durable Capital Partners LP10% Owner | $837K | Added | |||
| Trade date Jul 31 at $62.00/share; second tranche on same day as $1.41M buy; combined GSHD institutional buying $2.25M; now $66.95 (+8.0% since buy) | ||||||
| TLSATiziana Life Sciences Ltd | Elrifi IvorCEO | $667K | Added | |||
| Trade date Aug 3 at $1.00/share; CEO buying 667K shares in micro-cap biotech; now $0.99 (−1.0% since buy) | ||||||
| BGBunge Global SA | Mahoney ChristopherDirector | $528K | Added | |||
| Trade date Jul 31 at $105.53/share; now $106.62 (+1.0% since buy) | ||||||
| HLIHoulihan Lokey, Inc. | Alley J LindseyCFO | $501K | Added | |||
| Trade date Aug 3 at $124.52/share; CFO conviction buy; now $128.19 (+3.0% since buy) | ||||||
| TSCOTractor Supply Co. | Lawton Harry A IIIPresident & CEO | $417K | Added | |||
| Trade date Aug 4 at $32.20/share; now $33.41 (+3.8% since buy); CEO buying | ||||||
| EVGNEvogene Ltd. | Recanati LeonDirector | $400K | Added | |||
| Trade date Aug 4 at $0.50/share; 800K shares in Israeli ag-biotech micro-cap; now $0.631 (+26.2% since buy) | ||||||
| ACOGAlpha Cognition Inc. | Opaleye Management Inc.10% Owner | $400K | Added | |||
| Trade date Aug 3 at $8.00/share; institutional 10%+ holder adding; now $8.52 (+6.5% since buy) | ||||||
| WCCWESCO International Inc. | Castillo Daniel JEVP & GM, EES | $351K | Added | |||
| Trade date Aug 4 at $365.89/share; now $373.08 (+2.0% since buy) | ||||||
| JMKEJersey Mike's Subs Inc. | Peterson StacyPresident & COO | $345K | Added | |||
| Trade date Jul 31 at $23.00/share; recently public restaurant chain COO buying; now $23.14 (+0.6% since buy) | ||||||
| ASPSAltisource Portfolio Solutions | Benefit Street Partners LLC10% Owner | $283K | Added | |||
| Trade date Aug 3 at $5.78/share; institutional 10%+ holder; now $5.59 (−3.3% since buy) | ||||||
| GBFHGBank Financial Holdings Inc. | Newgard Jeffrey KPresident/CEO | $280K | Added | |||
| Trade date Aug 3 at $21.75/share; community bank CEO buying own stock; now $20.39 (−6.3% since buy) | ||||||
Scanned the last 24 hours of EDGAR Form 4 filings (762 total filed Aug 5–6, 2026). 23 qualifying buys (≥ $250K, transaction type P) totalling $36.8M. Data sourced directly from SEC EDGAR Form 4 XML filings.
Top signal — BSX CEO conviction: Mahoney's $9.0M open-market buy is the largest single executive purchase in this scan. He added 186,240 shares to his 1.4M direct position at a price he's now slightly underwater on ($47.74 vs $48.33). Medical devices CEO deploying personal capital at scale.
APMD already a winner (+65.7%): Morningside Venture Investments (HK-based VC, 10%+ owner) bought $5M in Apnimed sleep apnea biotech at $16 on Aug 3. Stock is now $26.51 — the biggest price move of any buy in this scan. May have been catalyzed by clinical data or partnership news.
COE cluster — CEO buying $8.1M over 3 days: Jack Huang (CEO, 51Talk / China Online Education Group) bought steadily Jul 28–30 across three sessions totalling $8.1M at $16.88–$17.21. Stock is now $18.99 (+10–12%). Strong CEO accumulation in a Chinese ADR. Late SEC filings filed Aug 5.
CVNA director already up 12.6%: Director Maroone's $1.3M buy at $61.69 (Jul 31) is now $69.48 — Carvana has had a strong run and this insider is in the green quickly.
PFE dual-director cluster: Blaylock ($999K) and Buckley ($960K) both bought Pfizer on Aug 5 — textbook cluster signal. Buckley (former Vanguard CEO) establishing a first position at the $25–26 floor. PFE remains range-bound on pipeline uncertainty; dual board conviction buys are notable.
Sector themes: Healthcare/biotech (BSX, APMD, PFE×2, TLSA, ACOG, EVGN) dominates with 7 qualifying buys. Chinese ADR (COE) and industrials (IR, WCC, TSCO) also active. Micro-cap/small-cap CEO buys (GBFH, JMKE, EVGN, GBFH) signal broad confidence across market caps.
Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.
SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →
See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.
Open the live chartOpen in the Stocks tab© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.